Farther Finance Advisors, LLC
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 1992825
SAN FRANCISCO, CA
Position in BTAI
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$33
-$7 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 40 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. BTAI ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,645 | $1,376,555 | |
| 2 | VTRS |
Viatris Inc
|
43,117 | $582,510 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
818 | $485,057 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
20,825 | $432,327 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,947 | $388,237 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
11,677 | $386,158 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,152 | $335,898 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,828 | $330,174 |
All Filings in BTAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33 | 25 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $40 | 25 | Shares | Sole | 2026-01-23 | |
| 2025-03-31 | $10 | 5 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||